Gabapentin Capsules — Class II drug recall D-0330-2015
Terminated recall by Aurobindo Pharma USA Inc, reported 2015-01-14, distributed nationwide. Failed Tablet/Capsule Specifications: Complaints of empty capsules received.
| Recall number | D-0330-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aurobindo Pharma USA Inc, Dayton, NJ, United States |
| Recall initiated | 2014-10-17 |
| Classified | 2015-01-06 |
| Reported by FDA | 2015-01-14 |
| Terminated | 2016-05-23 |
| Distributed | Nationwide (US) |
| Quantity | 24,816 bottles |
| NDC | 16714-0661, 16714-0661-01, 16714-0661-02, 16714-0661-03, 16714-0662, 16714-0662-01, 16714-0662-02, 16714-0662-03, 16714-0663, 16714-0663-01, 16714-0663-02 |
| Lot numbers | 12/15, GESB14011-A |
Product
Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.
Reason for recall
Failed Tablet/Capsule Specifications: Complaints of empty capsules received.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0330-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.